AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Salmeterol + Fluticasone in Zambia
5 products registered with ZAMRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Flutiair -S 250 Powder for inhalation Aerosol podwer | 313/007 | Sava Healthcare Limited | active | 14 Aug 2030 |
| Seretide inhaler Solution for Inhalation | 179/039 | GlaxoSmithKline South Africa (Pty) Ltd | active | 9 Mar 2030 |
| Seretide inhaler Inhalation aerosol | 179/040 | GlaxoSmithKline South Africa (Pty) Ltd | active | 9 Mar 2030 |
| Seretide inhaler Solution for Inhalation | 179/041 | GlaxoSmithKline South Africa (Pty) Ltd | active | 9 Mar 2030 |
| Seretide inhaler Solution for Inhalation | 179/042 | GlaxoSmithKline South Africa (Pty) Ltd | active | 7 Feb 2027 |
Salmeterol + Fluticasone — ZAMRA Registration Details
ZAMRA (Zambia) has 5 registered products containing Salmeterol + Fluticasone, of which 5 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Salmeterol + Fluticasone registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.